Nephrogenic Systemic Fibrosis (NSF)
Nephrogenic Systemic Fibrosis (nsf) is a rare disease caused by exposure to gadolinium-based contrast agents
Nephrogenic Systemic Fibrosis (NSF) was first described in the medical literature in 2000, with the first case of NSF bering identified identified in 1997.
The cause of NSF is unknown but it has been reported only in patients who have severe kidney disease. NSF causes fibrosis of the skin and connective tissues throughout the body which results in skin thickening that may prevent bending and extending joints, resulting in decreased mobility of joints.
Over time, NSF becomes worse and can cause death.
There is no known treatment for NSF.
Symptoms of Nephrogenic Systemic Fibrosis (NSF)
Patients with severe renal insufficiency (severe kidney disease) should pay particular attention to the following symptoms of nephrogenic systemic fibrosis:
- Skin and eyes
- swelling, hardening and tightening of your skin
- reddened or darkened patches on the skin
- burning or itching of your skin
- yellow raised spots on the whites of your eyes
- Bones and muscles
- stiffness in your joints
- problems moving or straightening arms, hands, legs, or feet
- pain deep in your hip bones or ribs
- muscle weakness
Contact your doctor right away after receiving a GBCA if you develop any of these symptoms that may indicate the development of NSF.
Free legal consultation
If you or a loved one have been injured by a gadolinium-based contrast agent (GBCA), if you have been diagnosed with nephrogenic systemic fibrosis, or if you are experiencing the symptoms associated with nephrogenic systemic fibrosis (NSF), you may have a claim against the manufacturers of these gadolinium-based contrast agents.
Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.